Katherine Lu

691 total citations
38 papers, 555 citations indexed

About

Katherine Lu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Katherine Lu has authored 38 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Katherine Lu's work include Cancer therapeutics and mechanisms (9 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cancer Treatment and Pharmacology (5 papers). Katherine Lu is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cancer Treatment and Pharmacology (5 papers). Katherine Lu collaborates with scholars based in United States, Canada and China. Katherine Lu's co-authors include Ti Li Loo, Niramol Savaraj, Robert S. Benjamin, Lynn G. Feun, Hwee‐Yong Yap, Stephen W. Hall, T. L. Loo, John A. Benvenuto, Gerald P. Bodey and Michael A. Burgess and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Clinical Pharmacology & Therapeutics and Biochimie.

In The Last Decade

Katherine Lu

34 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine Lu United States 13 273 238 107 102 60 38 555
Jörg Hartmann Germany 6 178 0.7× 215 0.9× 67 0.6× 167 1.6× 52 0.9× 8 577
Hiromi Tanii Japan 12 269 1.0× 340 1.4× 57 0.5× 57 0.6× 25 0.4× 19 536
Mona Lisa Banquerigo United States 12 185 0.7× 261 1.1× 60 0.6× 35 0.3× 26 0.4× 14 733
Y.-H. Ling United States 13 226 0.8× 333 1.4× 26 0.2× 84 0.8× 30 0.5× 24 582
Rebecca R. Thomas United States 10 562 2.1× 253 1.1× 52 0.5× 110 1.1× 74 1.2× 10 897
James E. Gervasoni United States 10 352 1.3× 393 1.7× 26 0.2× 70 0.7× 37 0.6× 15 725
S.H. Rosenberg United States 8 182 0.7× 356 1.5× 74 0.7× 33 0.3× 27 0.5× 12 588
Sian Anderson United Kingdom 5 254 0.9× 275 1.2× 44 0.4× 94 0.9× 56 0.9× 7 502
Ken‐ichi Akamatsu United States 14 292 1.1× 357 1.5× 39 0.4× 33 0.3× 59 1.0× 31 793
Jianguo Ma China 18 359 1.3× 487 2.0× 107 1.0× 131 1.3× 69 1.1× 49 879

Countries citing papers authored by Katherine Lu

Since Specialization
Citations

This map shows the geographic impact of Katherine Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Lu more than expected).

Fields of papers citing papers by Katherine Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Lu. The network helps show where Katherine Lu may publish in the future.

Co-authorship network of co-authors of Katherine Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Lu. A scholar is included among the top collaborators of Katherine Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Lu. Katherine Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Katherine, Kathy Kornas, & Laura C. Rosella. (2024). Predictive Modelling of Diabetes Risk in Population Groups Defined by Socioeconomic and Lifestyle Factors in Canada: A Cross-Sectional Study. International Journal of Public Health. 69. 1607060–1607060.
2.
3.
Savaraj, Niramol, et al.. (1992). Pharmacology of intrathecal VP-16-213 in dogs. Journal of Neuro-Oncology. 13(3). 211–5. 10 indexed citations
4.
Savaraj, Niramol, Jan C. Liang, Katherine Lu, Lynn G. Feun, & T. C. Hsü. (1989). Genotoxicity of [1H]Benz [de] isoquinoline-1, 3[2H]Dione, 5 Amino-2-, [2-(Dimethylamino) ethyl] (BIDA) in Human Lymphocytes. Cancer Investigation. 7(2). 117–121. 4 indexed citations
5.
Lu, Katherine, Mark A. McLean, Marvin L. Vestal, & Robert A. Newman. (1988). Pharmacokinetics of Amonafide in dogs. Cancer Chemotherapy and Pharmacology. 21(2). 134–8. 4 indexed citations
6.
Lu, Katherine, et al.. (1988). Pharmacokinetics of homoharringtonine in dogs. Cancer Chemotherapy and Pharmacology. 21(2). 139–42. 15 indexed citations
7.
Savaraj, Niramol, Lynn G. Feun, Katherine Lu, et al.. (1986). Clinical pharmacology of intracarotid etoposide. Cancer Chemotherapy and Pharmacology. 16(3). 292–294. 3 indexed citations
8.
Lu, Katherine, et al.. (1986). Clinical pharmacolinetics of 9, 10-anthracenedicarboxaldehyde-bis [(4,5-dihydro-1H-imidazol-2-yl)hydrazone]dihydrochloride. Cancer Chemotherapy and Pharmacology. 16(2). 156–9. 2 indexed citations
9.
Lu, Katherine, et al.. (1985). High-performance liquid chromatographic separation and quantitation of benzisoquinolinedione (Nafidimide) from biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 345(2). 408–412. 3 indexed citations
10.
Leavens, Milam E., Katherine Lu, Wang Ym, et al.. (1984). Central nervous system pharmacology of Baker's antifolate (NSC139105) in man. Journal of Neuro-Oncology. 2(3). 187–93. 6 indexed citations
11.
Stewart, DavidJ., Zhengang Guo, Katherine Lu, et al.. (1984). Human tissue distribution of 4?-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA). Cancer Chemotherapy and Pharmacology. 12(2). 116–9. 8 indexed citations
12.
Lu, Katherine, Niramol Savaraj, Agop Y. Bedikian, et al.. (1983). Clinical pharmacology of 2,5′-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ). European Journal of Cancer and Clinical Oncology. 19(5). 603–606. 4 indexed citations
13.
Loo, Ti Li, Jiushi Liu, Katherine Lu, & Niramol Savaraj. (1983). Clinical pharmacokinetics of 5-methyltetrahydrohomofolate.. PubMed. 43(2). 921–4. 1 indexed citations
14.
Savaraj, Niramol, Katherine Lu, Lynn G. Feun, et al.. (1983). Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986). Journal of Neuro-Oncology. 1(1). 15–9. 35 indexed citations
15.
Savaraj, Niramol, et al.. (1982). Pharmacology of mitoxantrone in cancer patients. Cancer Chemotherapy and Pharmacology. 8(1). 113–117. 54 indexed citations
16.
Lu, Katherine & T. L. Loo. (1980). The pharmacologic fate of the antitumor agent 2-amino-1,3,4-thiadiazole in the dog. Cancer Chemotherapy and Pharmacology. 4(4). 275–9. 7 indexed citations
17.
Lu, Katherine & Ti Li Loo. (1980). Pharmacological disposition of 1,4-bis (2-[(2-hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate in the dog.. PubMed. 40(5). 1427–30. 14 indexed citations
18.
Loo, Ti Li, Stephen W. Hall, Philip A. Salem, Robert S. Benjamin, & Katherine Lu. (1978). Clinical pharmacological and toxicological studies of Cis-diamminedichloroplatinum (II) by continuous intravenous infusion. Biochimie. 60(9). 957–960. 11 indexed citations
19.
Benvenuto, John A., Katherine Lu, Stephen W. Hall, Robert S. Benjamin, & Ti Li Loo. (1978). Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.. PubMed. 38(11 Pt 1). 3867–70. 56 indexed citations
20.
Loo, Ti Li, Stephen W. Hall, Philip A. Salem, Robert S. Benjamin, & Katherine Lu. (1978). 45 Clinical, pharmacological and toxicological studies of cis-diammine-dichloroplatinum (II) (DDP) by continuous intravenous infusion. Biochimie. 60(9). 1067–1067. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jörg Hartmann Breakdown of academic impact, for papers by Hiromi Tanii Breakdown of academic impact, for papers by Mona Lisa Banquerigo Breakdown of academic impact, for papers by Y.-H. Ling Breakdown of academic impact, for papers by Rebecca R. Thomas Breakdown of academic impact, for papers by James E. Gervasoni Breakdown of academic impact, for papers by S.H. Rosenberg Breakdown of academic impact, for papers by Sian Anderson Breakdown of academic impact, for papers by Ken‐ichi Akamatsu Breakdown of academic impact, for papers by Jianguo Ma
Rankless by CCL
2026